Hummingbird Diagnostics Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Private

  • Employees
  • 26

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $708K

  • Investors
  • 2

Hummingbird Diagnostics General Information

Description

Developer of novel miRNA-based blood-borne diagnostics intended for early disease detection of indications. The company's developed blood-based diagnostic tests for the selection of late-stage NSCLC patients most likely to benefit from immunotherapies to deliver immediate value and actionable clinical guidance, enabling healthcare providers to more tailored treatment to patients.

Contact Information

Website
www.hummingbird-diagnostics.com
Formerly Known As
Febit Biomed, Comprehensive Biomarker Center
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
  • Im Neuenheimer Feld 583
  • 69120 Heidelberg
  • Germany
+49 06221 0000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hummingbird Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Grant 29-Apr-2020 $708K Completed Generating Revenue
7. Later Stage VC Completed Generating Revenue
6. Secondary Transaction - Private 01-Jan-2007 Completed Generating Revenue
5. Later Stage VC 25-May-2005 Completed Generating Revenue
4. Bankruptcy: Admin/Reorg 11-Oct-2004 Completed Bankruptcy: Admin/Reorg
3. Early Stage VC 19-Nov-2002 000.00 000.00 Completed Startup
2. Early Stage VC (Series B) 26-Oct-2001 $20M $20M Completed Startup
1. Early Stage VC Completed Startup
To view Hummingbird Diagnostics’s complete valuation and funding history, request access »

Hummingbird Diagnostics Patents

  • 158

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 20

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Hummingbird Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022327551-A1 Advanced dumbbell pcr for isomir detection Pending 11-Aug-2021
CA-3191516-A1 Advanced dumbbell pcr for isomir detection Pending 11-Aug-2021
EP-4168581-B1 Advanced dumbbell pcr for isomir detection Active 11-Aug-2021
EP-4168581-A1 Advanced dumbbell pcr for isomir detection Active 11-Aug-2021
EP-3899043-A2 Mirnas as biomarkers for parkinson's syndrome Pending 18-Dec-2018 C12Q1/6883
To view Hummingbird Diagnostics’s complete patent history, request access »

Hummingbird Diagnostics Executive Team (8)

Name Title Board Seat Contact Info
Jochen Kohlhaas Chief Executive Officer & Co-Founder
Rastislav Horos Ph.D Chief Technology Officer
Bruno Steinkraus Ph.D Chief Scientific Officer
Karoly Nikolich Ph.D Co-Founder & Board Member
You’re viewing 4 of 8 executive team members. Get the full list »

Hummingbird Diagnostics Board Members (7)

Name Representing Role Since
Bernd Seibel Self Vice Chairman 000 0000
Jörg Debatin MD Self Board Member 000 0000
Karoly Nikolich Ph.D Self Co-Founder & Board Member 000 0000
Michael Hadjisavas Hummingbird Diagnostics Board Member 000 0000
Scott Gazelle Ph.D Self Chairman 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Hummingbird Diagnostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hummingbird Diagnostics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alzheimers Drug Discovery Foundation Not-For-Profit Venture Capital 000 0000 000000 0
GreyBird Ventures Venture Capital Minority 000 0000 000000 0
To view Hummingbird Diagnostics’s complete investors history, request access »

Ready to get started?

Request a free trial